2008Zhongguo zhongyiyao xinxi zazhiRequires access

Effects of Buqi Huoxue Decoction on Levels of β-AP,TGF-α and IGF-II in Rats of Multi-Factor AD Model

Jiang Guohua

Open publisher page 0 citations

Abstract

Objective To observe the effects of Buqi Huoxue Decoction on levels of β-AP,TGF-α and IGF-Ⅱ in rats of multi-factor AD model and investigate the mechanism of treating AD with Buqi Huoxue Decoction. Method Multi-factor AD Model was established with D-galactose and SCOP by abdominal injection,AlCl3 by perfusion and QA by hippocampus injection. All rats were randomly divided into five groups:A (control group),B (pseudo injuried group),C (model group),D (Buqi Huoxue Decoction group) and E (hydergine group). Group D was treated by Buqi Huoxue Decoction and group E was treated by hydergine. β-AP,TGF-α and IGF-Ⅱ level in the blood of AD model were detected by radio-immuno-assay after treatment course. Results β-AP,TGF-α and IGF-Ⅱ level in the blood of group D and E were decreased significantly compared with group C after treatment. Conclusion Buqi Huoxue Decoction could decrease the high level of β-AP,TGF-α and IGF-II in the blood of multi-factor AD model,so as to achieve the therapeutic effect.

About this research paper

What this paper is about

Objective To observe the effects of Buqi Huoxue Decoction on levels of β-AP,TGF-α and IGF-Ⅱ in rats of multi-factor AD model and investigate the mechanism of treating AD with Buqi Huoxue Decoction. Method Multi-factor AD Model was established with D-galactose and SCOP by abdominal injection,AlCl3 by perfusion and QA by hippocampus injection. All rats were randomly divided into five groups:A (control group),B (pseudo injuried group),C (model group),D (Buqi Huoxue Decoction group) and E (hydergine group). Group D was treated by Buqi Huoxue Decoction and group E was treated by hydergine. β-AP,TGF-α and IGF-Ⅱ level in the blood of AD model were detected by radio-immuno-assay after treatment course. Results β-AP,TGF-α and IGF-Ⅱ level in the blood of group D and E were decreased significantly compared with group C after treatment. Conclusion Buqi Huoxue Decoction could decrease the high level of β-AP,TGF-α and IGF-II in the blood of multi-factor AD model,so as to achieve the therapeutic effect.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of Buqi Huoxue Decoction on levels of β-AP,TGF-α and IGF-Ⅱ in rats of multi-factor AD model and investigate the mechanism of treating AD with Buqi Huoxue Decoction. Method Multi-factor AD Model was established with D-galactose and SCOP by abdominal injection,AlCl3 by perfusion and QA by hippocampus injection. All rats were randomly divided into five groups:A (control group),B (pseudo injuried group),C (model group),D (Buqi Huoxue Decoction group) and E (hydergine group). Group D was treated by Buqi Huoxue Decoction and group E was treated by hydergine. β-AP,TGF-α and IGF-Ⅱ level in the blood of AD model were detected by radio-immuno-assay after treatment course. Results β-AP,TGF-α and IGF-Ⅱ level in the blood of group D and E were decreased significantly compared with group C after treatment. Conclusion Buqi Huoxue Decoction could decrease the high level of β-AP,TGF-α and IGF-II in the blood of multi-factor AD model,so as to achieve the therapeutic effect.

Key concepts: Decoction, Medicine, Transforming growth factor, Internal medicine, Traditional medicine, Endocrinology, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Buqi Huoxue Decoction on Levels of β-AP,TGF-α and IGF-II in Rats of Multi-Factor AD Model — Research Paper | ScholarLens